Updates from the Exchange
Predicting Menopause: There Just May be a Test for That
Amphora Shows Promise in Clinical Trials
U.S. Food and Drug Administration Approves First Generic Contraceptive Vaginal Ring
Microneedle Patch Delivers Long-Acting Reversible Contraception
Is a once-a-month birth control pill on the horizon?
Takeaways from the 2019 FDA Complex Generic Drug Product Development Workshop
LILETTA® levonorgestrel-releasing intrauterine system now FDA-approved for use for up to 6 years
The Initiative for Multipurpose Prevention Technologies (IMPT) Ten-Year Retrospective Report
Pressing Pause on Your Fertility: Contraception via Egg Hibernation
The Demographic and Health Surveys (DHS) Program Updates Questionnaires
NICHD Releases Five-Year Strategic Plan
Rebuilding Incentives for Research and Development of Medicines